Tue, May 9, 2023
Mon, May 8, 2023
Sun, May 7, 2023
Fri, May 5, 2023

Etzer Darout Initiated (ACRV) at Buy and Held Target at $25 on, May 8th, 2023

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. t-buy-and-held-target-at-25-on-may-8th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Etzer Darout of BMO Capital, Initiated "Acrivon Therapeutics, Inc." (ACRV) at Buy and Held Target at $25 on, May 8th, 2023.

Etzer has made no other calls on ACRV in the last 4 months.



There is 1 other peer that has a rating on ACRV. Out of the 1 peers that are also analyzing ACRV, 0 agree with Etzer's Rating of Hold.



This is the rating of the analyst that currently disagrees with Etzer


  • Emily Bodnar of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $24 on, Tuesday, May 2nd, 2023